AChR antibody pathogenicity in the context of MG is well documented, but it remains unclear in ALS, since passive transfer models using serum or IgG from AChR, as well as Lrp4 and Agrin antibody-positive ALS patients, have not yet been reported. The gene discussed is LRP4; the disease is myasthenia gravis.